Literature DB >> 16517868

Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.

Gunnstein Norheim1, Einar Rosenqvist, Abraham Aseffa, Mohammed Ahmed Yassin, Getahun Mengistu, Afework Kassu, Dereje Fikremariam, Wegene Tamire, E Arne Høiby, Tsegaye Alebel, Degu Berhanu, Yarid Merid, Morten Harboe, Dominique A Caugant.   

Abstract

The objectives of this study were to collect and characterize epidemic meningococcal isolates from Ethiopia from 2002 to 2003 and to compare them to 21 strains recovered during the previous large epidemic of 1988 to 1989. Ninety-five patients in all age groups with clinical signs of meningitis and a turbid cerebrospinal fluid (CSF) sample were included in the study of isolates from 2002 to 2003. Seventy-one patients (74.7%) were confirmed as having Neisseria meningitidis either by culture (n = 40) or by porA PCR (n = 31) of their CSF. The overall case fatality rate (CFR) was 11.6%; the N. meningitidis-specific CFR was 4.2%. All 40 strains were fully susceptible to all antibiotics tested except sulfonamide, were serotyped as A:4/21:P1.20,9, and belonged to sequence type 7 (ST-7). The strains from 1988 to 1989 were also equally susceptible and were characterized as A:4/21:P1.20,9, but they belonged to ST-5. Antigenic characterization of the strains revealed differences in the repertoire of lipooligosaccharides and Opa proteins between the old and the recent strains. PCR analysis of the nine lgt genes revealed the presence of the lgtAHFG genes in both old and recent strains; lgtB was present in only some of the strains, but no correlation with sequence type was observed. Further analysis showed that in addition to their pgm alleles, the Ethiopian ST-5 and ST-7 strains also differed in their tbpB, opa, fetA, and lgtA genes. The occurrence of new antigenic structures in strains sharing the same serogroup, PorA, and PorB may help explain the replacement of ST-5 by ST-7 in the African meningitis belt.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517868      PMCID: PMC1393097          DOI: 10.1128/JCM.44.3.861-871.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  50 in total

1.  Meningococcal disease, serogroup W135, Burkina Faso. Preliminary report, 2002.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2002-05-03

2.  Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis.

Authors:  M K Taha
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries.

Authors:  Luis Jódar; F Marc LaForce; Costante Ceccarini; Teresa Aguado; Dan M Granoff
Journal:  Lancet       Date:  2003-05-31       Impact factor: 79.321

4.  A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A.

Authors:  M Achtman; B Kusecek; G Morelli; K Eickmann; J F Wang; B Crowe; R A Wall; M Hassan-King; P S Moore; W Zollinger
Journal:  J Infect Dis       Date:  1992-01       Impact factor: 5.226

5.  Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis.

Authors:  B Linz; M Schenker; P Zhu; M Achtman
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

6.  Identification of a gene (lpt-3) required for the addition of phosphoethanolamine to the lipopolysaccharide inner core of Neisseria meningitidis and its role in mediating susceptibility to bactericidal killing and opsonophagocytosis.

Authors:  Fiona G Mackinnon; Andrew D Cox; Joyce S Plested; Christoph M Tang; Katherine Makepeace; Philip A Coull; J Claire Wright; Ronald Chalmers; Derek W Hood; James C Richards; E Richard Moxon
Journal:  Mol Microbiol       Date:  2002-02       Impact factor: 3.501

7.  Phase variation in meningococcal lipooligosaccharide biosynthesis genes.

Authors:  A W Berrington; Y-C Tan; Y Srikhanta; B Kuipers; P van der Ley; I R A Peak; M P Jennings
Journal:  FEMS Immunol Med Microbiol       Date:  2002-12-13

8.  Genetic diversity of three lgt loci for biosynthesis of lipooligosaccharide (LOS) in Neisseria species.

Authors:  Peixuan Zhu; Michael J Klutch; Margaret C Bash; Raymond S W Tsang; Lai-King Ng; Chao-Ming Tsai
Journal:  Microbiology       Date:  2002-06       Impact factor: 2.777

9.  Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa.

Authors:  P Nicolas; L Décousset; V Riglet; P Castelli; R Stor; G Blanchet
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

10.  NadA, a novel vaccine candidate of Neisseria meningitidis.

Authors:  Maurizio Comanducci; Stefania Bambini; Brunella Brunelli; Jeannette Adu-Bobie; Beatrice Aricò; Barbara Capecchi; Marzia Monica Giuliani; Vega Masignani; Laura Santini; Silvana Savino; Dan M Granoff; Dominique A Caugant; Mariagrazia Pizza; Rino Rappuoli; Marirosa Mora
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

View more
  15 in total

1.  Laboratory-based surveillance for patients with acute meningitis in Sudan, 2004-2005.

Authors:  S Afifi; M S Karsany; M Wasfy; G Pimentel; A Marfin; R Hajjeh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-12       Impact factor: 3.267

2.  Genetic and structural characterization of L11 lipooligosaccharide from Neisseria meningitidis serogroup A strains.

Authors:  Noëlle Mistretta; Delphine Seguin; Jerôme Thiébaud; Sandrine Vialle; Frédéric Blanc; Marina Brossaud; Philippe Talaga; Gunnstein Norheim; Monique Moreau; Bachra Rokbi
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

3.  Analysis of the bactericidal response to an experimental Neisseria meningitidis vesicle vaccine.

Authors:  Elizabeth E Moran; Robert Burden; Joseph E Labrie; Zhiyun Wen; Xin-Min Wang; Wendell D Zollinger; Lan Zhang; Valerian B Pinto
Journal:  Clin Vaccine Immunol       Date:  2012-03-29

4.  Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7.

Authors:  Gunnstein Norheim; Abraham Aseffa; Mohammed Ahmed Yassin; Getahun Mengistu; Afework Kassu; Dereje Fikremariam; Wegene Tamire; Yared Merid; E Arne Høiby; Dominique A Caugant; Elisabeth Fritzsønn; Torill Tangen; Tsegaye Alebel; Degu Berhanu; Morten Harboe; Einar Rosenqvist
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

5.  Measurement of functional anti-meningococcal serogroup a activity using strain 3125 as the target strain for serum bactericidal assay.

Authors:  Jan T Poolman; Isabel De Vleeschauwer; Nathalie Durant; Nathalie Devos; Christiane Feron; Pascal Lestrate; Vincent Weynants; Dominique Boutriau
Journal:  Clin Vaccine Immunol       Date:  2011-05-18

6.  Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.

Authors:  Gunnstein Norheim; Abraham Aseffa; Mohammed Ahmed Yassin; Getahun Mengistu; Afework Kassu; Dereje Fikremariam; Wegene Tamire; Yared Merid; E Arne Høiby; Dominique A Caugant; Elisabeth Fritzsønn; Torill Tangen; Berhanu Melak; Degu Berhanu; Morten Harboe; Jan Kolberg; Einar Rosenqvist
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

7.  Awareness of meningococcal disease among travelers from the United Kingdom to the meningitis belt in Africa.

Authors:  Anna L Goodman; Cristina Masuet-Aumatell; Jay Halbert; Jane N Zuckerman
Journal:  Am J Trop Med Hyg       Date:  2014-06-02       Impact factor: 2.345

8.  Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.

Authors:  Rolando Pajon; Andrew M Fergus; Dan M Granoff
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

9.  Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.

Authors:  Rolando Pajon; Andrew M Fergus; Oliver Koeberling; Dominique A Caugant; Dan M Granoff
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

10.  Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008.

Authors:  Caroline L Trotter; Seydou Yaro; Berthe-Marie Njanpop-Lafourcade; Aly Drabo; Sita S Kroman; Regina S Idohou; Oumarou Sanou; Leah Bowen; Helen Findlow; Serge Diagbouga; Bradford D Gessner; Ray Borrow; Judith E Mueller
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.